GNE-783
GNE-783 is a selective CHK1 inhibitor that enhances the activity of gemcitabine. GNE-783 improves the efficacy of anti-metabolite DNA damage drugs by inactivating S-phase and G2-phase cell cycle checkpoints following DNA damage. GNE-783 selectively enhances the chemical synergy of certain drugs in different tumor types, for example, enhancing the activity of temozolomide only in melanoma cell lines[1].
Product Specifications
CAS Number
1200127-66-7
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gne-783.html
Smiles
N#CC1=NC=C2C(C3=CC(C4=CC=C(N5CCN(C)CC5)C=C4)=CN=C3N2)=C1
Molecular Formula
C22H20N6
Molecular Weight
368.43
References & Citations
[1]Identification of preferred chemotherapeutics for combining with a CHK1 inhibitor
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Tyrosinase-Related Protein-1 (TYRP-1) (Melanoma Marker) (TYRP1/3282), CF405S conjugate, 0.1mg/mL
![BCL10 (122-168) Mouse Monoclonal Antibody [Clone ID: BL10/411]](https://cdn.genprice.uk/products/937/68dd189e061270361e8fd38e/imageurl/am32814pu-t.webp)
BCL10 (122-168) Mouse Monoclonal Antibody [Clone ID: BL10/411]
